alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
EXECUTIVE OFFICE OF THE PRESIDENT

OFFICE OF THE UNITED STATES TRADE REPRESENTATIVE

WASHINGTON, D.C. 20508

September 26, 2019

RE: Product Exclusion Request Number USTR-2018-0025-6627

Invacare Corp:

The purpose of this letter is to inform you that the product exclusion request referenced 

above has been denied. As you are aware, USTR published a Federal Register notice (83 FR 

28710) on June 20, 2018, that announced the Trade Representative’s determination to impose an 

additional duty of 25 percent on certain products from China. On July 11, 2018, the Trade 

Representative published a Federal Register notice (83 FR 32181) which announced that a 

process had been established under which interested persons could request that products falling 

within a covered HTSUS subheading be excluded from the additional duties announced on June 

20.

Your request was reviewed in accordance with the factors and procedures set forth in 

Section B(1) of the July 11 notice. Based on that review, and after careful consideration, your 

request was denied because the request did not contain a sufficient product identification or was 

determined to be non-administrable.

Because USTR will grant exclusion requests on a product specific basis, you may still 

benefit from a product exclusion if a similar product is granted an exclusion. Products for which 

an exclusion has been granted will be periodically announced on the USTR website. Product 

exclusions will become legally effective once published in the Federal Register. 

Sincerely,

Joseph Barloon

General Counsel
<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5
<MULTIPLIER> 1,000
       
<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          DEC-31-1998
<PERIOD-START>                             JAN-01-1998
<PERIOD-END>                               JUN-30-1998
<CASH>                                           3,008
<SECURITIES>                                         0
<RECEIVABLES>                                      498
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                                     0
<PP&E>                                         140,959
<DEPRECIATION>                                     244
<TOTAL-ASSETS>                                 164,765
<CURRENT-LIABILITIES>                                0
<BONDS>                                        115,514
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                            28
<OTHER-SE>                                      32,997
<TOTAL-LIABILITY-AND-EQUITY>                   164,765
<SALES>                                              0
<TOTAL-REVENUES>                                13,539
<CGS>                                                0
<TOTAL-COSTS>                                        0
<OTHER-EXPENSES>                                11,368
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                               6,054
<INCOME-PRETAX>                                (3,883)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                            (3,883)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                   (3,887)
<EPS-PRIMARY>                                        0
<EPS-DILUTED>                                        0
        

</TABLE>
<TABLE> <S> <C>

<ARTICLE> 9
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
COMPANY'S FINANCIAL STATEMENTS FOR THE YEAR ENDED SEPTEMBER 30, 1999 AND IS
QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>
<MULTIPLIER> 1,000

<S>                             <C>
<PERIOD-TYPE>                   YEAR
<FISCAL-YEAR-END>                          SEP-30-1999
<PERIOD-START>                             OCT-01-1998
<PERIOD-END>                               SEP-30-1999
<CASH>                                          29,074
<INT-BEARING-DEPOSITS>                           3,488
<FED-FUNDS-SOLD>                                     0
<TRADING-ASSETS>                                     0
<INVESTMENTS-HELD-FOR-SALE>                  1,136,528
<INVESTMENTS-CARRYING>                          40,285
<INVESTMENTS-MARKET>                            40,084
<LOANS>                                      1,122,011
<ALLOWANCE>                                      9,356
<TOTAL-ASSETS>                               2,473,356
<DEPOSITS>                                   1,484,303
<SHORT-TERM>                                   588,790
<LIABILITIES-OTHER>                             22,801
<LONG-TERM>                                    245,948
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                           146
<OTHER-SE>                                     131,368
<TOTAL-LIABILITIES-AND-EQUITY>               2,473,356
<INTEREST-LOAN>                                 80,467
<INTEREST-INVEST>                               62,438
<INTEREST-OTHER>                                 2,640
<INTEREST-TOTAL>                               145,545
<INTEREST-DEPOSIT>                              57,375
<INTEREST-EXPENSE>                              93,282
<INTEREST-INCOME-NET>                           52,263
<LOAN-LOSSES>                                    1,920
<SECURITIES-GAINS>                               (253)
<EXPENSE-OTHER>                                  8,826
<INCOME-PRETAX>                                 23,066
<INCOME-PRE-EXTRAORDINARY>                      23,066
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                    16,656
<EPS-BASIC>                                       1.78
<EPS-DILUTED>                                     1.70
<YIELD-ACTUAL>                                    2.51
<LOANS-NON>                                      2,840
<LOANS-PAST>                                       607
<LOANS-TROUBLED>                                     0
<LOANS-PROBLEM>                                      0
<ALLOWANCE-OPEN>                                 7,530
<CHARGE-OFFS>                                      447
<RECOVERIES>                                        50
<ALLOWANCE-CLOSE>                                9,356
<ALLOWANCE-DOMESTIC>                             9,356
<ALLOWANCE-FOREIGN>                                  0
<ALLOWANCE-UNALLOCATED>                              0


</TABLE>
[Federal Register Volume 86, Number 107 (Monday, June 7, 2021)]
[Notices]
[Page 30323]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-11879]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Center for Scientific Review; Amended Notice of Meeting

    Notice is hereby given of a change in the meeting of the Center for 
Scientific Review Special Emphasis Panel, June 22, 2021, 10:00 a.m. to 
June 22, 2021, 08:00 p.m., National Institutes of Health, Rockledge II, 
6701 Rockledge Drive, Bethesda, MD 20892 which was published in the 
Federal Register on May 18, 2021, 86 FR 26931.
    Lawrence Kagemann, Ph.D., <a href="/cdn-cgi/l/email-protection#54183526262d7a1f35333139353a3a141a3d3c7a133b22"><span class="__cf_email__" data-cfemail="1f537e6d6d6631547e787a727e71715f51767731587069">[email protected]</span></a>, (301) 480-6849, 
will be the new Contact person, replacing Inna Gorshkova as Scientific 
Review Officer. The meeting date and location remain the same. The 
meeting is closed to the public.

David W. Freeman,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2021-11879 Filed 6-4-21; 8:45 am]
BILLING CODE 4140-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
#### STATE of Missouri, Respondent, v. Arnold BELL, Appellant. Arnold BELL, Appellant, v. STATE of Missouri, Respondent.

Nos. WD 47263, WD 49713.

Missouri Court of Appeals, Western District.

April 4, 1995.

Laura G. Martin, Asst. Appellate Defender, Kansas City, for appellant.

Jeremiah W. (Jay) Nixon, Atty. Gen., Christine M. Kocot, Asst. Atty. Gen., Jefferson City, for respondent.

Before SPINDEN, P.J., and ULRICH and SMART, JJ.

ORDER

PER CURIAM.

Arnold Bell appeals his convictions after a jury trial of first degree assault and armed criminal action. He also appeals the denial of his motion for post-conviction relief. Finding no jurisprudential purpose in publishing a written opinion, we affirm his convictions and the denial of his motion for post-conviction relief by this summary order. Rules 30.25(b) and 84.16(b).
EXHIBIT 32.2

                    CERTIFICATION OF CHIEF FINANCIAL OFFICER
                       PURSUANT TO 18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In  connection  with the Quarterly  Report of Panorama  Investments  Corp.  (the
"Company")  on Form 10-QSB for the period  ending  August 31, 2005 as filed with
the Securities  and Exchange  Commission on the date hereof (the  "Report"),  I,
Steven Bekropoulos, Chief Financial Officer of the Company, certify, pursuant to
18 U.S.C.  ss.1350,  as adopted pursuant to ss.906 of the  Sarbanes-Oxley Act of
2002, that:

     (1)  The Report fully complies with the requirements of section 13(a) or
          15(d) of the Securities Exchange Act of 1934; and

     (2)  The information contained in the Report fairly presents, in all
          material respects, the financial condition and result of operations of
          the Company.

IN WITNESS  WHEREOF,  the undersigned has executed this  certification as of the
26th day of October, 2005.

/s/ Steven Bekropoulos
---------------------------
Chief Financial Officer
EXHIBIT 32.1

                CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350

In  connection  with  the  Quarterly  Report  of W.  S.  INDUSTRIES,  INC.  (the
"COMPANY") on Form 10-QSB for the period ending  November 30, 2006 as filed with
the Securities  and Exchange  Commission on the date hereof (the  "REPORT"),  I,
James F. Dempsey,  President and Chief Executive Officer,  respectively,  of THE
COMPANY,  certify,  pursuant to 18 U.S.C.  section 1350, as adopted  pursuant to
Section 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:

     1.   The Report fully  complies with the  requirements  of Section 13(a) or
          15(d) of the Securities Exchange Act of 1934, as amended; and

     2.   The  information  contained  in the  Report  fairly  presents,  in all
          material respects, the financial condition and  results  of operations
          of THE COMPANY.

Date:  January 19, 2007

                                             By: /s/ JAMES F. DEMPSEY
                                                 ---------------------
                                                 James F. Dempsey
                                                 Chief  Executive  Officer
Exhibit 32.1

Certification of CEO Pursuant to

18 U.S.C. Section 1350,

As Adopted Pursuant to

Section 906 of the Sarbanes-Oxley Act of 2002

In connection with the Annual Report on Form 10-K of First State Bancorporation, a New
Mexico corporation (the Company), for the period ended December 31, 2007, as filed with the Securities and Exchange Commission on the date hereof (the Report), I, Michael R. Stanford, as President and Chief Executive
Officer of the Company, hereby certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to §906 of the Sarbanes-Oxley Act of 2002, that to the best of my knowledge:

(1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

A signed original of this written statement required by Section 906 has been provided to First State Bancorporation and will be retained by First
State Bancorporation and furnished to the Securities and Exchange Commission or its staff upon request.



|                                     
|-------------------------------------
|                                     
|/s/ Michael R. Stanford              
|Michael R. Stanford                  
|President and Chief Executive Officer
|March 17, 2008                       

This certification accompanies the Report pursuant to §906 of the Sarbanes-Oxley Act of 2002 and shall not,
except to the extent required by the Sarbanes-Oxley Act of 2002, be deemed filed by the Company for purposes of §18 of the Securities Exchange Act of 1934, as amended.
[Federal Register Volume 86, Number 106 (Friday, June 4, 2021)]
[Notices]
[Page 30060]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-11711]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Allergy and Infectious Diseases; Notice of 
Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Allergy and Infectious 
Diseases Special Emphasis Panel; Integrated Preclinical/Clinical 
AIDS Vaccine Development Program (IPCAVD) (U19 Clinical Trial Not 
Allowed).
    Date: June 30, 2021.
    Time: 10:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institute of Allergy and Infectious Diseases, 
National Institutes of Health, 5601 Fishers Lane, Room 3G36, 
Rockville, MD 20892 (Virtual Meeting).
    Contact Person: Poonam Pegu, Ph.D., Scientific Review Officer, 
Scientific Review Program, DEA/NIAID/NIH/DHHS, 5601 Fishers Lane, 
MSC-9823, Rockville, MD 20892, 240-292-0719, <a href="/cdn-cgi/l/email-protection#7f0f1010111e12510f1a180a3f11161751181009"><span class="__cf_email__" data-cfemail="6c1c0303020d01421c090b192c020504420b031a">[email protected]</span></a>.

(Catalogue of Federal Domestic Assistance Program Nos. 93.855, 
Allergy, Immunology, and Transplantation Research; 93.856, 
Microbiology and Infectious Diseases Research, National Institutes 
of Health, HHS)

    Dated: May 28, 2021.
Tyeshia M. Roberson,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2021-11711 Filed 6-3-21; 8:45 am]
BILLING CODE 4140-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
EXHIBIT 32

CERTIFICATION

Pursuant to 18 U.S.C. 1350 as adopted by Section 906 of the Sarbanes-Oxley Act
of 2002

Each of the undersigned, W. Bruce Johnson, Interim Chief Executive Officer and President of Sears Holdings Corporation (the
Company) and Michael D. Collins, Senior Vice President and Chief Financial Officer of the Company, has executed this certification in connection with the filing with the Securities and Exchange Commission of the Companys Quarterly
Report on Form 10-Q for the fiscal quarter ended May 2, 2009 (the Report).

Each of the undersigned hereby certifies
that:



| | 1. | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
| | -- | ---------------------------------------------------------------------------------------------------------------------



| | 2. | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
| | -- | ----------------------------------------------------------------------------------------------------------------------------------------------------

May 28, 2009



|                                                              
|--------------------------------------------------------------
|/s/ W. Bruce Johnson                                          
|W. Bruce Johnson Interim Chief Executive Officer and
President



|                                                                    
|--------------------------------------------------------------------
|/s/ Michael D. Collins                                              
|Michael D. Collins Senior Vice President and Chief Financial Officer
Exhibit
      32.1


**CERTIFICATION
      PURSUANT TO**


18
      U.S.C.
      SECTION 1350


AS
      ADOPTED PURSUANT TO


SECTION
      906 OF THE SARBANES-OXLEY ACT OF 2002





I,
      Darren
      Stevenson, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant
      to
      Section 906 of the Sarbanes-Oxley Act of 2002, that the Quarterly Report on
      Form
      10-QSB of Blacksands
      Petroleum, Inc. ,
      for the
      fiscal quarter ended July 31, 2007 fully complies with the requirements of
      Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that the
      information contained in the Quarterly Report on Form 10-QSB fairly presents
      in
      all material respects the financial condition and results of operations of Blacksands
      Petroleum, Inc.





Date:
                September 14, 2007
            By:
            /s/ Darren R. StevensonDarren
                R. Stevenson, Principal Executive
                Officer
<PAGE>

                                                                  EXHIBIT 24.1

Gateway, Inc.
From 10-K; Power of Attorney

         Each of the undersigned constitutes and appoints William M. Elliott and
Stephanie G. Heim, or either of them, as the undersigned's true and lawful
attorney-in-fact and agent, with full power of substitution, in the
undersigned's name, place and stead, in any and all capacities, to sign an
Annual Report on Form 10-K of Gateway, Inc. (the "Company") for the Company's
fiscal year ended December 31, 2000, and any amendment thereto, and to file the
same, with all exhibits thereto and other documents in connection therewith
(collectively, the "Form 10-K"), with the Securities and Exchange Commission,
the New York Stock Exchange and such other state and federal government
commissions and agencies as required under the Securities Act of 1934, as
amended, the regulations thereunder and other applicable law.

Dated: January 19, 2001

<TABLE>
<CAPTION>

<S>                                                                 <C>
                                                                                     TITLE

/s/ Theodore W. Waitt                                                Chairman of the Board and Chief Executive
--------------------------------------------------------             Officer and Director
Theodore W. Waitt


/s/ Elizabeth Dole
--------------------------------------------------------             Director
Elizabeth Dole


/s/ Charles G. Carey
--------------------------------------------------------             Director
Charles G. Carey


/s/ George H. Krauss
--------------------------------------------------------             Director
George H. Krauss


/s/ Douglas L. Lacey
--------------------------------------------------------             Director
Douglas L. Lacey


/s/ James F. McCann
--------------------------------------------------------             Director
James F. McCann


/s/ Richard D. Snyder
--------------------------------------------------------             Director
Richard D. Snyder
</TABLE>
This disposition is not appropriate for publication and is not precedent *

except as provided by 9th Cir. R. 36-3.

The panel unanimously concludes this case is suitable for decision **

without oral argument. See Fed. R. App. P. 34(a)(2).

NOT FOR PUBLICATION

UNITED STATES COURT OF APPEALS

 FOR THE NINTH CIRCUIT

UNITED STATES OF AMERICA,

 Plaintiff - Appellee,

 v.

EFRAIN RODRIGUEZ,

 Defendant - Appellant.

No. 10-10593

D.C. No. 5:08-cr-00925-JW

MEMORANDUM*

Appeal from the United States District Court

for the Northern District of California

James Ware, Chief Judge, Presiding

Submitted March 6, 2012** 

Before: B. FLETCHER, REINHARDT, and TASHIMA, Circuit Judges. 

Efrain Rodriguez appeals from the 78-month sentence imposed following his

guilty-plea conviction for possession with intent to distribute 50 grams or more of

methamphetamine, in violation of 21 U.S.C. § 841(a)(1) and (b)(1)(A)(viii). 

FILED

MAR 12 2012

MOLLY C. DWYER, CLERK

U.S. COURT OF APPEALS
2 10-10593

We dismiss. 

Rodriguez contends that he was denied effective assistance of counsel at

sentencing when counsel failed to complete his investigation, to submit a

sentencing memorandum, or to adequately prepare for the sentencing hearing. We

are precluded from reaching the merits of Rodriguez’s claim by a valid appeal

waiver in which Rodriguez gave up his right to pursue a direct appeal of his

sentence. See United States v. Nunez, 223 F.3d 956, 959 (9th Cir. 2000) (“[O]ne

waives the right to argue ineffective assistance of counsel at sentencing on direct

appeal when one waives the right to appeal the sentence.”).

In any event, the record is insufficiently developed and Rodriguez’s legal

representation was not so inadequate that it can be concluded at this point that he

obviously was denied his Sixth Amendment right to counsel. See United States v.

McKenna, 327 F.3d 830, 845 (9th Cir. 2003) (“Claims of ineffective assistance of

counsel are generally inappropriate on direct appeal.”).

DISMISSED.
[Federal Register Volume 60, Number 57 (Friday, March 24, 1995)]
[Notices]
[Page 15557]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 95-7245]



-----------------------------------------------------------------------


DEPARTMENT OF ENERGY

Notice of Additional Environmental Training Courses

March 20, 1995.
    The Office of Pipeline Regulation staff will conduct the following 
training during FY 95. A more detailed announcement will be made for 
each individual session as the locations and times are finalized.

------------------------------------------------------------------------
          Type of training                Date            Location      
------------------------------------------------------------------------
Cultural Resources.................  May 3........  Minneapolis.        
                                     Sept. 14 or    Denver.             
                                      21                                
Compliance.........................  May..........  New Orleans.        
Environmental Report Preparation     August.......  Salt Lake City.     
 and Compliance.                     September....  Detroit.            
------------------------------------------------------------------------

    The Cultural Resources and Compliance training will be similar to 
previous sessions. The Environmental Report Preparation training will 
be a new one-day session on how to prepare an environmental report and 
related information for construction projects filed with the 
Commission. It will be held in conjunction with a two-day Compliance 
session.
    We would appreciate any suggestions for additional training topics 
and additional locations for training sessions. Please provide any 
questions or suggestions about these or other training sessions, to Mr. 
John Leiss at (202) 208-1106.
Lois D. Cashell,
Secretary.
[FR Doc. 95-7245 Filed 3-23-95; 8:45 am]
BILLING CODE 6717-01-M